Alpha-1 Antitrypsin Blood Test – Indications, Procedure, Results

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Article Summary

Alpha-1 antitrypsin (AAT) deficiency is a clinically under-recognized genetic disorder that causes the defective production of alpha-1 antitrypsin protein. AAT protein protects the body from the neutrophil elastase enzyme, which is released from white blood cells to fight infection. This activity discusses the evaluation and management of AAT and highlights the role of the interprofessional team in managing and treating the disease to improve patient...

Key Takeaways

  • This article explains Why do I need this test? in simple medical language.
  • This article explains How the Test will Feel in simple medical language.
  • This article explains What other tests might I have along with this test? in simple medical language.
  • This article explains Why the Test is Performed in simple medical language.
Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.
Choose your reading view

Patient View highlights a simple learning journey. Clinical View reveals structure, evidence, and editorial completeness.

Definition

Alpha-1 antitrypsin (AAT) deficiency is a clinically under-recognized genetic disorder that causes the defective production of alpha-1 antitrypsin protein. AAT protein protects the body from the bacterial infection. সহজ বাংলা: ব্যাকটেরিয়ার বিরুদ্ধে লড়াই করা শ্বেত রক্তকণিকা।" data-rx-term="neutrophil" data-rx-definition="Neutrophil is a white blood cell important for fighting bacterial infection. সহজ বাংলা: ব্যাকটেরিয়ার বিরুদ্ধে লড়াই করা শ্বেত রক্তকণিকা।">neutrophil elastase enzyme, which is released from white blood cells to fight infection. This activity discusses the evaluation and management of AAT and highlights the role of the interprofessional team in managing and treating the disease to improve patient care.

This test measures the amount of alpha-1 antitrypsin (AAT) in the blood. AAT is a protein that is made in the liver. It helps protect your lungs from damage and diseases, such as emphysema and chronic obstructive pulmonary disease (COPD).

AAT is made by certain genes in your body. Genes are the basic units of heredity passed down from your parents. They carry information that determines your unique traits, such as height and eye color. Everyone inherits two copies of the gene that makes AAT, one from their father and one from their mother. If there is a mutation (change) in one or both copies of this gene, your body will make less AAT or AAT that doesn’t work as well as it should.

  • If you have two mutated copies of the gene, it means you have a condition called AAT deficiency. People with this disorder have a higher risk of getting lung disease or liver damage before the age of 45.
  • If you have one mutated AAT gene, you may have lower than normal amounts of AAT, but mild or no symptoms of disease. People with one mutated gene are carriers of AAT deficiency. This means you don’t have the condition, but you could pass the mutated gene on to your children.

An AAT test can help show if you have the genetic mutation that puts you at risk for disease.

Other names: A1AT, AAT, alpha-1-antiprotease deficiency, α1-antitrypsin alpha-1 antitrypsin is a diagnosis. সহজ বাংলা: রক্ত/প্রস্রাব/নমুনা পরীক্ষা।" data-rx-term="laboratory test" data-rx-definition="A laboratory test examines blood, urine, tissue, or other samples to help diagnosis. সহজ বাংলা: রক্ত/প্রস্রাব/নমুনা পরীক্ষা।">laboratory test to measure the amount of alpha-1 antitrypsin (A1AT) in your blood.

Why do I need this test?

The only way to find out whether you have this genetic disorder is to get tested.

Your healthcare provider may order this test if you have these problems:

  • Chronic wheezing

  • Asthma that can’t be controlled through aggressive treatment

  • Shortness of breath during mild exercise

  • Rapid heartbeat when you stand up

  • Vision problems

  • Chronic bronchitis

  • Bumpy or itchy skin

  • Chronic obstructive pulmonary disease (COPD)

  • Emphysema, a serious, progressive lung disease that causes breathing problems

  • Bronchiectasis, a lung problem that causes chronic dilation of the airways

  • Blood in your vomit

  • Swelling in your abdomen or legs

  • Unexplained liver problems, especially if they appear in childhood

  • Unintentional weight loss

Infants who have yellow skin, a sign of jaundice, may also be tested.

Your healthcare provider may also recommend the test if someone in your family has a history of the above conditions.

How the Test will Feel

When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or a slight bruise. This soon goes away.

What other tests might I have along with this test?

Your healthcare provider may recommend other tests to rule out other conditions:

  • Pulmonary function testing. A series of tests to see how well your lungs work.

  • Chest radiography. X-ray of your lungs.

  • HRCT (high-resolution CT) and densitometry. More detailed X-rays of your lungs and tests to measure any lung and liver damage.

  • Liver function tests. A series of blood tests to see how well your liver works.

  • Abdominal ultrasound. A test that uses sound waves to find evidence of liver damage.

  • Liver biopsy. A procedure that involves taking a tiny sample of your liver to look for disease.

Your healthcare provider may do a series of tests on the serum in your blood to find the damaged genes. These tests include:

  • Serum AAT concentrations. Tests on a blood sample to look for the AAT protein.

  • Serum protein electrophoresis with thin-layer isoelectric focusing. A more accurate test for the gene.

  • Genetic test. You may consider getting a genetic test before getting a blood test. The genetic test can be done with a blood sample or a swab from inside your mouth.

Why the Test is Performed

This test is helpful in identifying a rare form of emphysema in adults and a rare form of liver disease (cirrhosis) in children and adults caused by an A1AT deficiency. A1AT deficiency is passed down through families. The condition causes the liver to make too little of a protein that protects the lungs and liver from damage.

Everyone has two copies of the gene that makes A1AT. Most people with a lower-than-normal level of A1AT have one normal gene for A1AT and one abnormal gene. People with two abnormal copies of the gene have more severe diseases.

Why do I need an AAT test?

You may need an AAT test if you are under the age of 45, are not a smoker, and have symptoms of lung disease, including:

  • Wheezing
  • Shortness of breath
  • Chronic cough
  • Faster than normal heartbeat when you stand up
  • Vision problems
  • Asthma that doesn’t respond well to treatment

You may also get this test if you have a family history of AAT deficiency.

AAT deficiency in babies often affects the liver. So your baby may need an AAT test if his or her health care provider finds signs of liver disease. These include:

  • Jaundice, a yellowing of the skin and eyes that lasts for more than a week or two
  • An enlarged spleen
  • Frequent itching

Normal Results

Normal value ranges may vary slightly among different laboratories. Talk to your health care provider about the meaning of your specific test results.

What do the results mean?

If your results show a lower than normal amount of AAT, it probably means you have one or two mutated AAT genes. The lower the level, the more likely it is you have two mutated genes and AAT deficiency.

If you are diagnosed with AAT deficiency, you can take steps to reduce your risk of disease. These include:

  • Not smoking. If you are a smoker, quit smoking. If you don’t smoke, don’t start. Smoking is the leading risk factor for life-threatening lung disease in people with AAT deficiency.
  • Following a healthy diet
  • Getting regular exercise
  • Seeing your health care provider regularly
  • Taking medicines as prescribed by your provider
  • Damage of the large airways in the lungs ( bronchiectasis )
  • Scarring of the liver ( cirrhosis )
  • Chronic obstructive pulmonary disease (COPD)
  • Liver tumors
  • Yellowing of the skin and eyes due to blocked bile flow ( obstructive jaundice )
  • High blood pressure in the large vein leads to the liver (portal hypertension )

Risks

There is very little risk involved with having your blood taken. Veins and arteries vary in size from one person to another, and from one side of the body to the other. Taking blood from some people may be more difficult than from others.

Other risks associated with having blood drawn are slight, but may include:

  • Excessive bleeding
  • Fainting or feeling lightheaded
  • Hematoma (blood accumulating under the skin)
  • Infection (a slight risk any time the skin is broken)

Key points

  • All adults with chronic obstructive pulmonary disease, asthma with incompletely reversible airway obstruction or necrotizing panniculitis, as well as people of any age with unexplained liver disease, should be screened for alpha-1 antitrypsin deficiency.

  • Screening involves testing the serum alpha-1 antitrypsin level; the diagnosis must be confirmed by genotyping or phenotyping.

  • People with diagnosed alpha-1 antitrypsin deficiency should undergo full pulmonary function testing, chest radiography and liver enzyme and function testing.

  • Treatment of alpha-1 antitrypsin lung disease includes general treatment for chronic obstructive pulmonary disease and consideration of augmentation therapy.

CMAJ remains committed to notifying readers in a timely way about advisories and warnings pertaining to serious adverse drug events.

References

RX Medical Knowledge Graph

Explore this medical topic

Continue through verified related conditions, investigations, medicines, and patient guides. These links are educational and do not replace professional medical advice.

Written by Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist

Dr. Md. Harun Ar Rashid, MPH, MD, is a highly respected medical specialist celebrated for his exceptional clinical expertise and unwavering commitment to patient care. With advanced qualifications including MPH, MD he integrates cutting-edge research with a compassionate approach to medicine, ensuring that every patient receives personalized and effective treatment. His extensive training and hands-on experience enable him to diagnose complex conditions accurately and develop innovative treatment strategies tailored to individual needs. In addition to his clinical practice, Dr. Harun Ar Rashid is dedicated to medical education and research, writing and inventory creative thinking, innovative idea, critical care managementing make in his community to outreach, often participating in initiatives that promote health awareness and advance medical knowledge. His career is a testament to the high standards represented by his credentials, and he continues to contribute significantly to his field, driving improvements in both patient outcomes and healthcare practices. Born and educated in Bangladesh, Dr. Rashid earned his BPT from the University of Dhaka before pursuing postgraduate training internationally. He completed his MD in Internal Medicine at Anglia Ruskin University - Biomedical and Forensic Sciences, where he developed a special interest in inflammatory arthritis and metabolic bone disease. He then undertook a PhD in Orthopedic Science at the University of Oxford, conducting pioneering research on cytokine signaling pathways in rheumatoid arthritis. Following his doctoral studies, Dr. Rashid returned to clinical work with a fellowship in interventional pain management at the Asia E University, refining his skills in image-guided joint injections and minimally invasive pain-relief techniques.